- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Society for Cardiovascular Angiography and Interventions
DIPRA: Distal Radial Access Safe, No Negative Impact on Hand Function vs Proximal Radial Access
May 23, 2022
Data from an interim analysis of the DIPRA trial suggest distal radial artery access for cardiac catheterization and resulted in no significant differences in hand function compared to proximal radial artery access.
SAFE-PAD: No Difference in Mortality with Paclitaxel-Coated Devices Up to 6 Years Out
May 21, 2022
Long-term data from the SAFE-PAD trial at SCAI 2022 underlines the noninferiority of paclitaxel-coated devices versus non-drug-coat devices for use in patients with peripheral artery disease.
Clopidogrel Tops Aspirin for Long-Term Antiplatelet Therapy After PCI in High-Risk Patients
May 20, 2022
An analysis of data from the Fuwai PCI registry details the incidence of adverse events and risk of bleeding associated with clopidogrel monotherapy versus aspirin monotherapy 12 months post-PCI in high-risk patients.
Q&A on SCAI's 2022 PFO Guidelines, with Clifford Kavinsky, MD, PhD
May 20, 2022
Chair of the SCAI's writing group for their 2022 guidelines on management of patent foramen ovale, Dr. Clifford Kavinsky, sits down with Practical Cardiology to take part in a Q&A on the guideline's recommendations and the writing process for the SCAI's first PFO guidance.
Follow-up Results for Harmony TPV System Demonstrate Efficacy at 1-Year
May 02, 2021
Results of 1-year follow-up from the Harmony TPV Clinical trial provide insight into the safety and efficacy of the recently approved Harmony TPV system in patients with congenital heart disease and severe pulmonary regurgitation.
Presentations for Acute MIs Dropped Drastically During Peak of COVID-19 Pandemic
April 30, 2021
An analysis of data from NYU Langone provides perspective into the rapid decline of emergency department presentations for acute myocardial infarction that occurred during the peak of the COVID-19 pandemic.
SCAI 2021: ISCHEMIA Represents a Fraction of Patients with SIHD Undergoing PCI
April 29, 2021
An analysis comparing a national registry against ISCHEMIA enrollment criteria suggests trial eligibility represents less than 2% of all patients undergoing PCI and less than a third of patients undergoing PCI with stable ischemic heart disease.
Extended-Duration DAPT Reduces Mortality, Event Rate in TWILIGHT-like Patients
April 29, 2021
An SCAI 2021 analysis of more than 4k patients with characteristics similar to those included in the TWILIGHT trial indicates extended-duration DAPT, defined as a duration of more than 12 months post-PCI, was a more efficacious approach than short-term DAPT in this patient population.